In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Cancer Charities Join Forces to Launch New Trial for Women with an Aggressive Type of Breast Cancer
Ribozyme Pharmaceuticals initiates Angiozyme clinical
Competitive Technologies license bone cement technology
Nanophase and Competitive Technologies enter nanotechnology agreement
Competitive Technologies Obtains Exclusive Rights To Patented, Innovative Cancer Treatment
IBC Begins Phase I/II Clinical Trial Of Pentacea in Cancer Therapy
COMPETITIVE TECHNOLOGIES LICENSES HOMOCYSTEINE ASSAY TO DIAGNOSTIC PRODUCTS CORP.
Genzyme Molecular Oncology announces initiation of breast cancer clinical
Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
